CDSCO approves AstraZeneca Anticancer Drug Trastuzumab Deruxtecan Protocol Amendment Dr. Divya Colin21 Aug 2022 2:00 PM ISTNew Delhi: Based on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug...
DCGI nod to AstraZeneca India breast cancer drug Lynparza Ruchika Sharma20 Aug 2022 11:49 AM ISTEarly breast cancer is defined as the cancer confined to the breast with or without regional lymph node involvement and the absence of distant...
Thermo Fisher Scientific secures USFDA nod for Oncomine Dx Target Test for lung cancers with HER2 mutations Ruchika Sharma15 Aug 2022 12:00 PM ISTThe Oncomine Dx Target Test is designed to simultaneously evaluate 23 genes associated with NSCLC.
AstraZeneca concludes acquisition of TeneoTwo Ruchika Sharma15 Aug 2022 11:00 AM ISTAstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer Ruchika Sharma14 Aug 2022 3:30 PM ISTEnhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi...
AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer Ruchika Sharma6 Aug 2022 2:30 PM ISTEnhertu is a HER2-directed ADC.
AstraZeneca- MSD gets EU nod for Lynparza to treat early-stage breast cancer Ruchika Sharma5 Aug 2022 5:23 PM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
AstraZeneca India introduces Chronic Kidney Disease Academy Ruchika Sharma28 July 2022 1:45 PM ISTThe certificate training course on CKD latest updates will train about 1000 primary care physicians through three interactive modules.
CDSCO Panel nod to AstraZeneca Olaparib for BRCA Mutated HER2 Negative Breast Cancer Rahul Verma26 July 2022 5:48 PM ISTBased on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
AstraZeneca Olaparib gets CDSCO Panel okay for BRCA mutated HER2 negative breast cancer Dr. Divya Colin23 July 2022 6:00 PM ISTNew Delhi: Based on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug...
